Holen Sie sich die Stockscreener-App
1.16
11.54%
0.12
Handel nachbörslich:
1.15
-0.01
-0.86%
Schlusskurs vom Vortag:
$1.04
Offen:
$1.05
24-Stunden-Volumen:
81,454
Relative Volume:
2.17
Marktkapitalisierung:
$5.69M
Einnahmen:
$36.31M
Nettoeinkommen (Verlust:
$-5.98M
KGV:
-0.7813
EPS:
-1.4848
Netto-Cashflow:
$-6.17M
1W Leistung:
+14.85%
1M Leistung:
+4.50%
6M Leistung:
-24.18%
1J Leistung:
-26.11%
1-Tages-Spanne:
$1.05
$1.1714
1-Wochen-Bereich:
$1.02
$1.1714
52-Wochen-Spanne:
$1.00
$2.43
Sunshine Biopharma Inc Stock (SBFM) Company Profile
Firmenname
Sunshine Biopharma Inc
Sektor
Telefon
954-330-0684
Adresse
333 LAS OLAS WAY, FORT LAUDERDALE
Compare SBFM vs TAK, ZTS, HLN, TEVA, UTHR
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
SBFM
Sunshine Biopharma Inc
|
1.16 | 5.10M | 36.31M | -5.98M | -6.17M | -1.4848 |
TAK
Takeda Pharmaceutical Co Adr
|
18.22 | 59.20B | 29.85B | 776.90M | 4.35B | 0.2408 |
ZTS
Zoetis Inc
|
118.26 | 49.79B | 9.47B | 2.67B | 2.28B | 6.0218 |
HLN
Haleon Plc Adr
|
9.92 | 44.27B | 14.54B | 2.22B | 2.58B | 0.4871 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
29.82 | 35.03B | 17.41B | 1.43B | 1.00B | 1.2182 |
UTHR
United Therapeutics Corp
|
559.65 | 24.75B | 3.18B | 1.33B | 1.04B | 27.90 |
Sunshine Biopharma Inc Aktie (SBFM) Neueste Nachrichten
Sunshine Biopharma Reports Fiscal 2025 Revenue of $36.3 Million, a 4.1% Increase Over Prior Year - ACCESS Newswire
SBFM Reports Increased Revenue and Outlines Future Growth Plans - GuruFocus
Sunshine Biopharma (SBFM) Aims for Cost Reductions to Enhance Pr - GuruFocus
Sunshine Biopharma launched nine new drugs as 2025 sales hit $36.3M - Stock Titan
Sunshine Biopharma Inc. 2025 Annual Report: Generic Drug Portfolio, Proprietary Oncology & Antiviral Developments, and Corporate Strategy - Minichart
Sunshine Biopharma Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Sunshine Biopharma (NASDAQ: SBFM) 2025 revenue reaches $36.3M - Stock Titan
Sunshine Biopharma 2025 10-K: $36.3M Revenue, $(1.44) EPS - TradingView
Sunshine Biopharma, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
Aug Reactions: Is Sunshine Biopharma Inc Equity Warrant benefiting from interest rate changesQuarterly Performance Summary & High Accuracy Investment Entry Signals - baoquankhu1.vn
Sunshine Biopharma Delays Annual SEC Filing - TipRanks
[NT 10-K] Sunshine Biopharma Inc. SEC Filing - Stock Titan
SBFM PE Ratio & Valuation, Is SBFM Overvalued - Intellectia AI
Aug Wrap: Does Sunshine Biopharma Inc Equity Warrant stock have upside surprise potential - baoquankhu1.vn
Bear Alert: What are the future prospects of Sunshine Biopharma Inc Equity Warrant2026 Volume Leaders & Safe Capital Investment Plans - baoquankhu1.vn
Smart Money: Is Sunshine Biopharma Inc Equity Warrant benefiting from interest rate changesTrend Reversal & Weekly Top Gainers Alerts - baoquankhu1.vn
Sunshine Biopharma Inc expected to post a loss of 27 cents a shareEarnings Preview - TradingView
Guidance Update: What is the cash position of Sunshine Biopharma Inc Equity Warrant2026 Retail & Low Risk Entry Point Tips - baoquankhu1.vn
Sunshine Biopharma, Inc.: Fundamental Analysis and Financial Ratings | | US8677811064 - marketscreener.com
Revenue per share of Sunshine Biopharma Inc. – NASDAQ:SBFMW - TradingView
SBFM Forecast, Price Target & Analyst Ratings | SUNSHINE BIOPHARMA INC (NASDAQ:SBFM) - ChartMill
Sunshine Biopharma's March Milestone: A Strategic Financial Review () - aktiencheck.de
Returns Recap: What are the future prospects of Sunshine Biopharma Inc Equity Warrant2026 Top Gainers & Safe Swing Trade Setups - baoquankhu1.vn
Sunshine Biopharma Engages Aegis for Warrant Solicitation - TipRanks
Sunshine Biopharma engages Aegis for three-month warrant solicitation, 10% fee on proceeds - TradingView
Sunshine Biopharma (SBFM) taps Aegis to solicit exercises of outstanding warrants - Stock Titan
Risk Check: Will Sunshine Biopharma Inc outperform its industry peersTrade Analysis Summary & Community Verified Trade Signals - baoquankhu1.vn
Sunshine Biopharma (SBFM) Board May Effect Up-to 1-for-10 Reverse Split - Stock Titan
SBFM Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
Aug Gainers: Is Sunshine Biopharma Incs ROE strong enoughJuly 2025 Retail & Weekly High Momentum Picks - baoquankhu1.vn
SBFM Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Aug Retail: Is Sunshine Biopharma Inc Equity Warrant affected by consumer sentimentWeekly Stock Recap & Capital Efficiency Focused Strategies - baoquankhu1.vn
Fund Flows: What is the Moat Score of Sunshine Biopharma IncTrade Volume Report & Entry and Exit Point Strategies - baoquankhu1.vn
Market Review: What is Sunshine Biopharma Incs valuation compared to sector2025 Historical Comparison & Expert Verified Movement Alerts - baoquankhu1.vn
SBFMW Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
SBFM (Sunshine Biopharma) Total Inventories : $14.06 Mil (As of Sep. 2025) - GuruFocus
Sunshine Biopharma board authorized to consider reverse stock split By Investing.com - Investing.com Nigeria
Sunshine Biopharma board authorized to consider reverse stock split - Investing.com
Sunshine Biopharma Shareholders Approve Potential Reverse Stock Split - TipRanks
Sunshine Biopharma (SBFM) majority holder clears path for up to 1-for-10 reverse split - Stock Titan
Weekly Earnings: Will Sunshine Biopharma Inc. outperform its industry peersDollar Strength & High Win Rate Trade Alerts - mfd.ru
MSN Money - MSN
Is Sunshine Biopharma Inc. Equity Warrant benefiting from innovation trends2025 Buyback Activity & Verified Chart Pattern Signals - mfd.ru
SBFM Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
Is Sunshine Biopharma Inc. a defensive stockJuly 2025 Outlook & Breakout Confirmation Trade Signals - mfd.ru
Does Sunshine Biopharma Inc. Equity Warrant have declining or rising EPS2025 Volume Leaders & Daily Technical Stock Forecast Reports - mfd.ru
Can Sunshine Biopharma Inc. Equity Warrant stock continue upward trendQuarterly Market Review & Fast Moving Stock Trade Plans - mfd.ru
Is Sunshine Biopharma Inc. stock positioned for digital transformationJuly 2025 Trends & Reliable Price Breakout Alerts - mfd.ru
Market Outlook: Will Sunshine Biopharma Inc benefit from government policy2025 Bull vs Bear & Proven Capital Preservation Methods - baoquankhu1.vn
Sunshine Biopharma Announces Sudden Resignation of Chief Operating Officer - The Globe and Mail
Resistance Check: Is ZIMV benefiting from innovation trendsJuly 2025 Analyst Calls & Stepwise Entry and Exit Trade Signals - baoquankhu1.vn
Finanzdaten der Sunshine Biopharma Inc-Aktie (SBFM)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.35%
0.67%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):